IL222568A - A dosage form not intended for intravenous administration containing a solid composition of a biologically active liquid agent and its uses - Google Patents

A dosage form not intended for intravenous administration containing a solid composition of a biologically active liquid agent and its uses

Info

Publication number
IL222568A
IL222568A IL222568A IL22256812A IL222568A IL 222568 A IL222568 A IL 222568A IL 222568 A IL222568 A IL 222568A IL 22256812 A IL22256812 A IL 22256812A IL 222568 A IL222568 A IL 222568A
Authority
IL
Israel
Prior art keywords
dosage form
active agent
biologically active
solid formulation
intravenous dosage
Prior art date
Application number
IL222568A
Other languages
English (en)
Hebrew (he)
Other versions
IL222568A0 (en
Original Assignee
Paladin Labs Barbados Inc
Paladin Labs Europe Ltd
Paladin Labs Inc
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paladin Labs Barbados Inc, Paladin Labs Europe Ltd, Paladin Labs Inc, Labopharm Inc filed Critical Paladin Labs Barbados Inc
Publication of IL222568A0 publication Critical patent/IL222568A0/en
Publication of IL222568A publication Critical patent/IL222568A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL222568A 2010-04-23 2012-10-21 A dosage form not intended for intravenous administration containing a solid composition of a biologically active liquid agent and its uses IL222568A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32734810P 2010-04-23 2010-04-23
PCT/CA2011/000447 WO2011130834A1 (en) 2010-04-23 2011-04-21 Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof

Publications (2)

Publication Number Publication Date
IL222568A0 IL222568A0 (en) 2012-12-31
IL222568A true IL222568A (en) 2017-05-29

Family

ID=44833585

Family Applications (1)

Application Number Title Priority Date Filing Date
IL222568A IL222568A (en) 2010-04-23 2012-10-21 A dosage form not intended for intravenous administration containing a solid composition of a biologically active liquid agent and its uses

Country Status (6)

Country Link
US (1) US20130039864A1 (enExample)
EP (1) EP2563349A4 (enExample)
JP (2) JP2013530931A (enExample)
CA (1) CA2797098C (enExample)
IL (1) IL222568A (enExample)
WO (1) WO2011130834A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060198891A1 (en) 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
CA2797098C (en) * 2010-04-23 2019-03-26 Labopharm Inc. Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof
US11331271B2 (en) * 2016-05-27 2022-05-17 The Johns Hopkins University Buccal, sublingual and intranasal delivery of fospropofol
JP6912876B2 (ja) * 2016-10-06 2021-08-04 三洋化成工業株式会社 アクリル系医薬固形製剤用添加剤
GB2561009B (en) * 2017-03-31 2020-05-13 Altus Formulation Inc Non-ionic PVP-PLA block copolymers and pharmaceutical compositions derived therefrom
WO2021247463A1 (en) * 2020-06-02 2021-12-09 Purdue Research Foundation Formulation of monodisperse kinetically frozen polymer micelles via equilibration-nanoprecipitation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1120109A3 (en) * 2000-01-24 2002-07-10 Pfizer Products Inc. Rapidly disintegrating and fast dissolving solid dosage form
US6338859B1 (en) * 2000-06-29 2002-01-15 Labopharm Inc. Polymeric micelle compositions
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
US6780324B2 (en) * 2002-03-18 2004-08-24 Labopharm, Inc. Preparation of sterile stabilized nanodispersions
CA2503361C (en) * 2002-10-25 2012-02-28 Labopharm Inc. Controlled-release compositions
WO2005009357A2 (en) * 2003-07-23 2005-02-03 Pr Pharmaceuticals, Inc. Controlled release compositions
US20070202158A1 (en) * 2003-12-17 2007-08-30 Mgi Gp, Inc. Methods Of Administering Water-Soluble Prodrugs Of Propofol For Extended Sedation
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
WO2008035229A2 (en) * 2006-09-22 2008-03-27 Labopharm, Inc. Compositions and methods for ph targeted drug delivery
JP2010533730A (ja) * 2007-07-16 2010-10-28 ノースイースタン・ユニバーシティ 安定した治療用ナノ粒子
ES2731881T3 (es) * 2007-09-25 2019-11-19 Formulex Pharma Innovations Ltd Composiciones que comprenden compuestos activos lipófilos y método para su preparación
FR2930444B1 (fr) * 2008-04-29 2010-06-04 Servier Lab Micelles polymerisees
CA2797098C (en) * 2010-04-23 2019-03-26 Labopharm Inc. Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof

Also Published As

Publication number Publication date
WO2011130834A8 (en) 2013-01-10
JP2013530931A (ja) 2013-08-01
EP2563349A4 (en) 2014-03-19
CA2797098C (en) 2019-03-26
IL222568A0 (en) 2012-12-31
JP6572256B2 (ja) 2019-09-04
WO2011130834A1 (en) 2011-10-27
JP2017186346A (ja) 2017-10-12
CA2797098A1 (en) 2011-10-27
EP2563349A1 (en) 2013-03-06
US20130039864A1 (en) 2013-02-14

Similar Documents

Publication Publication Date Title
PL2629754T3 (pl) Kompozycja farmaceutyczna w postaci ciekłej do podawania składników czynnych
ZA201304858B (en) Active ingredient combinations comprising pyridylethylbenzamides and other active ingredients
EP2406379A4 (en) COMPOSITIONS AND METHODS FOR RELEASING BIOLOGICALLY ACTIVE RNA
SG10201605794PA (en) Stable Pharmaceutical Composition And Methods Of Using Same
PL2643010T3 (pl) Biologicznie aktywny kompleks i jego otrzymywanie
ZA201202855B (en) Transdermal pharmaceutical compositions comprising active agents
IL220465A0 (en) Methods and compositions for stable liquid drug formulations
IL233592B (en) The compounds active as p2x4 receptor antagonists and substances containing them for the prevention and treatment of neurogenic pain
IL222548A (en) Hydroxamic acid derivatives and their antimicrobial and antimicrobial preparations
IL223012B (en) Pharmacy preparations in the form of tablets with two layers containing atorvastatin and irbesartan
IL222568A0 (en) Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof
EP2794879A4 (en) COMPOSITIONS AND METHODS FOR RELEASING BIOLOGICALLY ACTIVE RNA
BR112012016736A2 (pt) composição , formulação farmacêutica e uso da composição"
IL209698A (en) Use of Niportimox for the preparation of pharmaceuticals and preparations containing this Niportimox
IL213711A (en) Nano-phenofibrate preparation
BR112012001151A2 (pt) complexo de substância ativa e formulação compreendendo o complexo de substância ativa
IL220620A (en) History of Naphthalene-1, 4-Deon and Pharmaceuticals containing them for use in the treatment of osteoporosis and osteopenia
EP2142209A4 (en) DISPERSIONS IN A PARTICULATE AEROSOL WITH ACTIVE PHARMACEUTICAL INGREDIENTS
IL217514A0 (en) Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof
IL226347A0 (en) Formulation of an influential factor
GB201019937D0 (en) Biologically active complex and its preparation
HK1178075A (en) Pharmaceutical composition and dosage forms of elinogrel and methods of use thereof
PL392344A1 (pl) Kompozycja kosmetyczna i zastosowanie kompozycji składników aktywnych do wytwarzania kompozycji kosmetycznej

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed